Szot Matthew K - Insider Non-Derivative Transactions at Cadrenal Therapeutics, Inc. (CVKD) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 29, 2025, Szot Matthew K's relationship to Cadrenal Therapeutics, Inc. (CVKD) is Officer (Chief Financial Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CVKD insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Szot Matthew K - Insider Non-Derivative Transactions of CVKD Common Stock

Szot Matthew K - Insider Non-Derivative Transactions at CVKD

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 30, 2025	Sell -- (Common Stock)	9933	6.97	0
Oct 28, 2025	Sell -- (Common Stock)	1800	13.99	9933
Oct 25, 2025	Sell -- (Common Stock)	1800	13.99	11733
Oct 14, 2025	Sell -- (Common Stock)	1800	14.07	13533
Oct 10, 2025	Sell -- (Common Stock)	1693	13.99	15333
Oct 7, 2025	Sell -- (Common Stock)	107	13.99	17026
Oct 2, 2025	Sell -- (Common Stock)	1700	13.99	17133
Sep 30, 2025	Sell -- (Common Stock)	100	14	18833
Sep 26, 2025	Sell -- (Common Stock)	10900	14.05	18933
Sep 25, 2025	Sell -- (Common Stock)	1500	14	29833
Aug 29, 2025	Sell -- (Common Stock)	400	14	31333
Aug 28, 2025	Sell -- (Common Stock)	1600	14	31733
Jan 25, 2023	Acquisition -- (Common Stock)	50000	0	500000